Celldex Therapeutics reported $655.41M in Equity Capital and Reserves for its fiscal quarter ending in June of 2025.


Equity Capital And Reserves Change Date
AbbVie USD 1.46B 1.86B Mar/2025
Amgen USD 7.43B 1.22B Jun/2025
Bristol-Myers Squibb USD 17.49B 100M Jun/2025
Celldex Therapeutics USD 655.41M 47.58M Jun/2025
Glaxosmithkline GBP 14.35B 683M Jun/2025
Pfizer USD 88.7B 1.64B Jun/2025
Roche Holding CHF 36.16B 3.28B Dec/2024